Metformin is the most studied medication for preventing type 2 diabetes. For prediabetes, typical dosing starts at 500 mg once or twice daily with meals, titrated to 1,500-2,000 mg/day as tolerated. In the landmark Diabetes Prevention Program, metformin reduced progression to type 2 diabetes by 31% — meaningful, but less than the 58% reduction from intensive lifestyle change. It is most useful for higher-BMI, younger, or post-gestational-diabetes patients.
How Metformin Works
Metformin is a biguanide that:
- Reduces hepatic glucose production (its primary effect)
- Improves peripheral insulin sensitivity
- Modestly delays intestinal glucose absorption
- Alters gut microbiome composition, which may contribute to glucose effects
It does not stimulate insulin secretion, so metformin alone does not cause low blood sugar (hypoglycemia). That safety profile is a major reason it is favored for prediabetes.
Typical Dosing for Prediabetes
Immediate-Release (IR)
- Week 1-2: 500 mg once daily with largest meal
- Week 3-4: 500 mg twice daily
- Week 5+: 1,000 mg twice daily if tolerated (target used in the DPP was 850 mg twice daily)
Extended-Release (ER)
- Starting dose: 500 mg once daily with evening meal
- Increase by 500 mg weekly to 1,500-2,000 mg once daily
- Max ER dose: 2,000 mg/day
Extended-release formulations are generally better tolerated and preferred for patients who have had GI side effects with IR metformin. Explore how metformin fits into the broader plan in our treatment hub.
Who the ADA Recommends It For
Per the 2024 ADA Standards of Care, metformin should be considered for prediabetes in adults who meet one or more of:
- BMI 35 kg/m² or higher
- Age under 60
- Prior gestational diabetes with persistent prediabetes
- Rising A1C despite structured lifestyle intervention
Effectiveness Evidence
| Study | Intervention | Reduction in T2D risk |
|---|---|---|
| DPP (2002) | Lifestyle (7% wt loss + 150 min/wk activity) | 58% at 3 years |
| DPP (2002) | Metformin 850 mg twice daily | 31% at 3 years |
| DPPOS (2015) | Metformin long-term | 18% at 15 years |
| Indian Diabetes Prevention Programme | Lifestyle + metformin | 28-29% at 3 years |
In DPP subgroup analyses, metformin was most effective in younger adults (25-44) and those with BMI ≥ 35 — approaching lifestyle-level efficacy in those groups.
Side Effects
Common (Up to 30% Initially)
- Diarrhea
- Nausea, abdominal discomfort
- Metallic taste
- Decreased appetite
GI symptoms usually improve within 2-4 weeks. Strategies to minimize them: start low, titrate slowly, take with food, switch to ER.
Less Common but Important
- Vitamin B12 deficiency: risk rises with dose and duration; check B12 every 2-3 years after long-term use
- Lactic acidosis: very rare; risk concentrated in severe kidney disease, liver failure, or acute illness
- Acute kidney injury triggers: hold metformin during dehydrating illness or before iodinated contrast in higher-risk patients
Contraindications and Monitoring
- Avoid if eGFR < 30 mL/min/1.73m²; use with caution 30-45
- Avoid in acute or decompensated heart failure
- Temporarily hold for iodinated contrast, surgery, or serious illness
- Monitor kidney function at baseline and at least annually
- Check vitamin B12 after 2-3 years of use, or sooner if anemia or neuropathy develops
Cost and Access
Generic metformin is among the cheapest prescriptions in the US — typically $4-$10 per month through retail pharmacy programs. Nearly all insurance plans cover metformin for prediabetes, even when prescribed off-label. FSA and HSA funds are eligible.
Metformin vs Lifestyle Change
The DPP showed lifestyle intervention nearly doubled the diabetes-prevention benefit of metformin. Whenever possible, structured lifestyle programs — ideally a CDC-recognized Diabetes Prevention Program — are the first-line intervention. Metformin is complementary, not competitive, with lifestyle change.
The Bottom Line
Metformin is a safe, inexpensive, well-studied option for preventing progression from prediabetes to type 2 diabetes. Typical dosing is 500 mg to 2,000 mg per day, titrated based on tolerance. It is not a replacement for weight loss and physical activity, which are nearly twice as effective, but it is a valuable addition for high-risk patients — especially those with higher BMI, under age 60, or with a history of gestational diabetes. Discuss with your doctor whether it fits your specific situation.
